Company Name: Protagonist Therapeutics, Inc.    

Protagonist Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the discovery and development of peptide-based new chemical entities using its proprietary peptide technology platform.

Ticker Symbol: PTGX (NASDAQ)

Company Website: www.protagonist-inc.com/

Headquarters: Milpitas, California